UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Clinical cancer research, 2009-04, Vol.15 (8), p.2856-2863

2009

Volltextzugriff (PDF)

Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas

Clinical cancer research, 2008-02, Vol.14 (3), p.715-720

2008

Volltextzugriff (PDF)

NEBULA: A multicenter phase 1a/b study of a tumor-selective transgene-expressing adenoviral vector, NG-641, and nivolumab in patients with metastatic or advanced epithelial tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2682-TPS2682

2022

Volltextzugriff (PDF)

Phase 1 clinical trial results for NG-350A, a novel transgene-armed and tumor-selective vector: Differential effects of intravenous (IV) versus intratumoral (IT) dosing on immune pharmacodynamics (PD)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2572-2572

2023

Volltextzugriff (PDF)

Safety and tolerability of T-SIGn vectors when administered using “flat” versus “low-high-high” (LHH) dosing regimens

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2572-2572

2022

Volltextzugriff (PDF)

FORTITUDE: Results of a phase 1a study of the novel transgene-armed and tumor-selective vector NG-350A with and without pembrolizumab (pembro)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2559-2559

2022

Volltextzugriff (PDF)

Long-Term Efficacy in MRI and No Evidence of Disease Activity Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Peginterferon Beta-1a (P7.266)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Abstract CT214: A multicenter phase 1a/b study of NG-641, a tumor-selective transgene-expressing adenoviral vector, and nivolumab in patients with metastatic or advanced epithelial tumors (NEBULA)

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT214-CT214

2022

Volltextzugriff (PDF)

Long-Term Safety and Tolerability of Peginterferon Beta-1a: Interim Analysis From ATTAIN, a Phase 3 Extension Study (S4.002)

Neurology, 2015-04, Vol.84 (14_supplement)

2015

Volltextzugriff (PDF)

Abstract CT213: A multicenter phase 1a/b study of NG-350A, a tumor-selective anti-CD40-antibody expressing adenoviral vector, and pembrolizumab in patients with metastatic or advanced epithelial tumors (FORTIFY)

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT213-CT213

2022

Volltextzugriff (PDF)

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique

International journal of MS care, 2016-07, Vol.18 (4), p.211-218

2016

Volltextzugriff (PDF)

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a

International journal of MS care, 2016-07, Vol.18 (4), p.211-218

2016

Volltextzugriff (PDF)

Vascular effects of anandamide and N‐acylvanillylamines in the human forearm and skin microcirculation

British journal of pharmacology, 2005-09, Vol.146 (2), p.171-179

2005

Volltextzugriff (PDF)

Treatment Monitoring by 18 F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors

Journal of Nuclear Medicine, 2008-07, Vol.49 (7), p.1038-1046

2008

Volltextzugriff (PDF)

Treatment Monitoring by ^sup 18^F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors

The Journal of nuclear medicine (1978), 2008-07, Vol.49 (7), p.1038

2008

Volltextzugriff (PDF)

Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors

The Journal of nuclear medicine (1978), 2008-07, Vol.49 (7), p.1038-1046

2008

Volltextzugriff (PDF)

Modulation of the inflammatory response to histamine by terbutaline and sodium nitroprusside in guinea-pig skin

Clinical physiology and functional imaging, 2005-11, Vol.25 (6), p.340-343

2005

Volltextzugriff (PDF)

Microvascular response in guinea pig skin to histamine challenge with and without application of skin window

Clinical physiology and functional imaging, 2004-09, Vol.24 (5), p.266-269

2004

Volltextzugriff (PDF)

Microvascular inflammatory response in the skin

Evilevitch, Vladimir

2005

Volltextzugriff (PDF)

Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. Commentary

British journal of pharmacology, 2005, Vol.146 (2), p.165-166

2005

Volltextzugriff (PDF)

Structure and Transport Properties of a Charged Spherical Microemulsion System

Langmuir, 2001-02, Vol.17 (4), p.1043-1053

2001

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(20)
Dissertationen
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Male
(6)
Science & Technology
(6)
Biological And Medical Sciences
(5)
Life Sciences & Biomedicine
(5)
Adult
(4)
Female
(4)
Humans
(4)
Medical And Health Sciences
(4)
Medical Sciences
(4)
Medicin Och Hälsovetenskap
(4)
Middle Aged
(4)
Pharmacology. Drug Treatments
(4)
Vasodilatation
(4)
Aged
(3)
Aged, 80 And Over
(3)
Animals
(3)
Basic Medicine
(3)
Fysiologi
(3)
Medicinska Och Farmaceutiska Grundvetenskaper
(3)
Neoadjuvant Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Reduction of Glucose Metabolic Activity Is More Accurate than Change in Size at Predicting Histopathologic Response to Neoadjuvant Therapy in High-Grade Soft-Tissue Sarcomas

NEBULA: A multicenter phase 1a/b study of a tumor-selective transgene-expressing adenoviral vector, NG-641, and nivolumab in patients with metastatic or advanced epithelial tumors

Phase 1 clinical trial results for NG-350A, a novel transgene-armed and tumor-selective vector: Differential effects of intravenous (IV) versus intratumoral (IT) dosing on immune pharmacodynamics (PD)

Safety and tolerability of T-SIGn vectors when administered using “flat” versus “low-high-high” (LHH) dosing regimens

FORTITUDE: Results of a phase 1a study of the novel transgene-armed and tumor-selective vector NG-350A with and without pembrolizumab (pembro)

Long-Term Efficacy in MRI and No Evidence of Disease Activity Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Peginterferon Beta-1a (P7.266)

Abstract CT214: A multicenter phase 1a/b study of NG-641, a tumor-selective transgene-expressing adenoviral vector, and nivolumab in patients with metastatic or advanced epithelial tumors (NEBULA)

Long-Term Safety and Tolerability of Peginterferon Beta-1a: Interim Analysis From ATTAIN, a Phase 3 Extension Study (S4.002)

Abstract CT213: A multicenter phase 1a/b study of NG-350A, a tumor-selective anti-CD40-antibody expressing adenoviral vector, and pembrolizumab in patients with metastatic or advanced epithelial tumors (FORTIFY)

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a: Obtaining Recommendations Using the Delphi Technique

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated with Peginterferon Beta-1a

Vascular effects of anandamide and N‐acylvanillylamines in the human forearm and skin microcirculation

Treatment Monitoring by 18 F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors

Treatment Monitoring by ^sup 18^F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors

Treatment Monitoring by 18F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors

Modulation of the inflammatory response to histamine by terbutaline and sodium nitroprusside in guinea-pig skin

Microvascular response in guinea pig skin to histamine challenge with and without application of skin window

Microvascular inflammatory response in the skin

Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. Commentary

Structure and Transport Properties of a Charged Spherical Microemulsion System

Suchergebnisse filtern